产品信息
参考资料(来源文献)
背景描述 | OE19, also known as JROECL19, was originally one of five permanent human oesophageal adenocarcinoma (EAC) cell lines established in 1993. It is from a stage III tumour of a 72 year old male patient1 and deposited in ECACC by Drs J C Rockett/A Morris, Department of Biological Sciences, University of Warwick and Dr S J Darnton, Birmingham Heartlands Hospital. Boonstra et al. discovered that cell lines SEG-1, BIC-1, and SK-GT-5 are not EAC cell lines but large cell lung cancer cell line H460, colorectal adenocarcinoma cell line SW620, and gastric fundus carcinoma cell line SKGT-2, respectively. However, they confirmed that cell lines FLO-1, KYAE-1, SK-GT-4, OE19, OE33, OACP4C, OACM5.1, ESO26, and ESO51 are derived from human EACs2 . All nine of these verified EAC cell lines, together with their genotyping information, have been deposited with ECACC. |
年龄(性别) | 男性;72岁 |
组织来源 | 食管癌 |
细胞类型 | 肿瘤细胞 |
肿瘤类型 | 食管癌细胞 |
生物安全等级 | BSL-1 |
倍增时间 | ~50-60 hours (DSMZ=ACC-700) |
致瘤性 | 裸小鼠致癌 |
保藏机构 | ECACC; 96071721 |
FAQs
Q:{{item.question}}
A:
暂无数据